Senseonics Holdings PE Ratio 2015-2023 | SENS
Current and historical p/e ratio for Senseonics Holdings (SENS) from 2015 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Senseonics Holdings PE ratio as of May 09, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Senseonics Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-09 | 0.48 | 0.00 | |
2023-12-31 | 0.57 | $-0.11 | 0.00 |
2023-09-30 | 0.60 | $-0.09 | 0.00 |
2023-06-30 | 0.76 | $-0.18 | 0.00 |
2023-03-31 | 0.71 | $-0.17 | 0.00 |
2022-12-31 | 1.03 | $-0.20 | 0.00 |
2022-09-30 | 1.32 | 0 | 0.00 |
2022-06-30 | 1.03 | $0.21 | 4.90 |
2022-03-31 | 1.97 | $-0.18 | 0.00 |
2021-12-31 | 2.67 | $-0.83 | 0.00 |
2021-09-30 | 3.39 | $-1.43 | 0.00 |
2021-06-30 | 3.84 | $-1.61 | 0.00 |
2021-03-31 | 2.64 | $-1.22 | 0.00 |
2020-12-31 | 0.87 | $-0.75 | 0.00 |
2020-09-30 | 0.39 | $-0.52 | 0.00 |
2020-06-30 | 0.39 | $-0.52 | 0.00 |
2020-03-31 | 0.63 | $-0.66 | 0.00 |
2019-12-31 | 0.92 | $-0.62 | 0.00 |
2019-09-30 | 0.99 | $-0.48 | 0.00 |
2019-06-30 | 2.04 | $-0.56 | 0.00 |
2019-03-31 | 2.45 | $-0.62 | 0.00 |
2018-12-31 | 2.59 | $-0.61 | 0.00 |
2018-09-30 | 4.77 | $-0.69 | 0.00 |
2018-06-30 | 4.11 | $-0.64 | 0.00 |
2018-03-31 | 3.00 | $-0.55 | 0.00 |
2017-12-31 | 2.66 | $-0.49 | 0.00 |
2017-09-30 | 3.19 | $-0.49 | 0.00 |
2017-03-31 | 1.79 | $-0.49 | 0.00 |
2016-12-31 | 2.67 | $-0.50 | 0.00 |
2016-09-30 | 3.90 | $-0.52 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.253B | $0.022B |
Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
10x Genomics (TXG) | United States | $3.022B | 0.00 |
Azenta (AZTA) | United States | $3.015B | 163.85 |
Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
Enovis (ENOV) | United States | $2.779B | 20.60 |
Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
Privia Health (PRVA) | United States | $2.238B | 99.26 |
Schrodinger (SDGR) | United States | $1.679B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 47.56 |
Phreesia (PHR) | United States | $1.237B | 0.00 |
Standard BioTools (LAB) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Talkspace (TALK) | United States | $0.451B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.342B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
American Well (AMWL) | United States | $0.150B | 0.00 |
Augmedix (AUGX) | United States | $0.128B | 0.00 |
TruBridge (TBRG) | United States | $0.121B | 5.17 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.094B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.051B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.012B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
ETAO (ETAO) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |